These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24981792)

  • 21. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis.
    Mandrioli J; Ferri L; Fasano A; Zucchi E; Fini N; Moglia C; Lunetta C; Marinou K; Ticozzi N; Drago Ferrante G; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Chiò A; Riva N; Logroscino G; Messina S; Calvo A
    Eur J Neurol; 2018 Jun; 25(6):861-868. PubMed ID: 29512869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort.
    Kacem I; Sghaier I; Bougatef S; Nasri A; Gargouri A; Ajroud-Driss S; Gouider R
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):131-139. PubMed ID: 31858811
    [No Abstract]   [Full Text] [Related]  

  • 23. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis.
    Khishchenko N; Allen KD; Coffman CJ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Oddone EZ; Rozear MP; Sabet A; Sams L; Bedlack RS
    Amyotroph Lateral Scler; 2010; 11(1-2):125-32. PubMed ID: 19153849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
    Pinto S; Pinto A; de Carvalho M
    Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.
    Raymond J; Oskarsson B; Mehta P; Horton K
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):413-420. PubMed ID: 31131638
    [No Abstract]   [Full Text] [Related]  

  • 27. Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.
    Broussalis E; Grinzinger S; Kunz AB; Killer-Oberpfalzer M; Haschke-Becher E; Hartung HP; Kraus J
    Acta Neurol Scand; 2018 Mar; 137(3):329-334. PubMed ID: 29148035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Course of Amyotrophic Lateral Sclerosis according to Initial Symptoms: An Analysis of 500 Cases.
    Lee JW; Kang SW; Choi WA
    Yonsei Med J; 2021 Apr; 62(4):338-343. PubMed ID: 33779087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
    J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seven amyotrophic lateral sclerosis patients diagnosed only after development of respiratory failure.
    Sato K; Morimoto N; Deguchi K; Ikeda Y; Matsuura T; Abe K
    J Clin Neurosci; 2014 Aug; 21(8):1341-3. PubMed ID: 24613427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
    Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
    Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.
    Sánchez-Martínez CM; Choreño-Parra JA; Nuñez-Orozco L; Placencia-Álvarez N; Alvis-Castaño LM; Guadarrama-Ortiz P
    BMC Neurol; 2019 Oct; 19(1):261. PubMed ID: 31664949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs.
    Galvin M; Ryan P; Maguire S; Heverin M; Madden C; Vajda A; Normand C; Hardiman O
    PLoS One; 2017; 12(6):e0179796. PubMed ID: 28640860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marital status is a prognostic factor in amyotrophic lateral sclerosis.
    Spataro R; Volanti P; Lo Coco D; La Bella V
    Acta Neurol Scand; 2017 Dec; 136(6):624-630. PubMed ID: 28470818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurophysiological index is associated with the survival of patients with amyotrophic lateral sclerosis.
    Cao B; Wei Q; Ou R; Zhang L; Hou Y; Chen Y; Shang H
    Clin Neurophysiol; 2019 Sep; 130(9):1730-1733. PubMed ID: 31164255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
    Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.